Authors response to the above comment by M. Vogt et al. on "New Directions: Enhancing the natural cycle to slow global warming"*

被引：2

作者：

Wingenter, Oliver W. ^{[1
,2
]}

Elliot, Scott M. ^{[3
]}

Blake, Donald R. ^{[4
]}

机构：

[1] New Mexico Inst Min & Technol, Dept Chem, Socorro, NM 87801 USA

[2] New Mexico Inst Min & Technol, Geophys Res Ctr, Socorro, NM 87801 USA

[3] Los Alamos Natl Lab, Climate Ocean Sea Ice Modeling Project, Los Alamos, NM 87545 USA

[4] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA

来源：

ATMOSPHERIC ENVIRONMENT | 2008年 / 42卷 / 19期

关键词：

D O I：

10.1016/j.atmosenv.2008.05.003

中图分类号：

X [环境科学、安全科学];

学科分类号：

08 ; 0830 ;

摘要：

引用

页码：4806 / 4809

页数：4

共 30 条

[21] Response on the comment by A. Sassella and M. Campione (08.08.2006) on the paper "Magnetic field influence on the molecular alignment of vanadyl phthalocyanine thin films" V. Kolotovska et al., J. Crystal Growth, 291, 166 (2006)
Kolotovska, V.
Paez S, B. A.
JOURNAL OF CRYSTAL GROWTH, 2007, 299 (02) : 437 - 437
[22] Comment on "Early Aptian paleoenvironmental evolution of the Bab Basin at the southern Neo-Tethys margin: Response to global carbon-cycle perturbations across Ocean Anoxic Event 1a" by K. Yamamoto et al.
Granier, Bruno R. C.
GEOCHEMISTRY GEOPHYSICS GEOSYSTEMS, 2014, 15 (05): : 2086 - 2090
[23] Comment on "Improving the efficiency of a CIGS solar cell to above 31% with Sb2S3 as a new BSF: a numerical simulation approach by SCAPS-1D" by M. F. Rahman and S. Goumri-Said et al., RSC Adv., 2024, 14, 1924
Kirk, Alexander P.
RSC ADVANCES, 2024, 14 (43) : 31655 - 31656
[24] Comments from the authors: F. Rupp, L. Scheideler, N. Olshanska, M. de wild, M. Wieland, and J. Geis-Gerstorfer of "Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces", J Biomed Mater Res 76A: 323-334 (2006), to the Letter to the Editor of M. Morra et al.
Rupp, F.
Scheideler, L.
Olshanska, N.
de Wild, M.
Wieland, M.
Geis-Gerstorfer, J.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 79A (03) : 755 - 757
[25] Comment on: Response to the Letter to the Editor by M. Hockel et al.: Laterally extended parametrectomy in node-positive early stage cervical cancer: Right direction, wrong track, by L. Ungar, Z. Novak, and L. Palfalvi
Hoeckel, Michael
GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 767 - 767
[26] miR-141, a new player, joins the senescence orchestra Comment on: Dimri M, et al. Cell Cycle 2013; 12; 3537-46; PMID:24091627; http://dx.doi.org/10.4161/cc.26592
Itahana, Yoko
Neo, Shu Hui
Itahana, Koji
CELL CYCLE, 2013, 12 (23) : 3586 - 3587
[27] Response to the comment by M. Lustrino on "high-pressure melting experiments on garnet clinopyroxenite and the alkalic-tholeiitic transition in ocean-island basalts" by Keshav et al. [Earth Planet. Sci. Lett. 223, 365-379 (2004)]
Keshav, S
Bizimis, M
Gudfinnsson, GH
Sen, G
Fei, YW
EARTH AND PLANETARY SCIENCE LETTERS, 2006, 241 (3-4) : 997 - 999
[28] Authors' reply to Comment on "Self-expandable metal stents for malignant colonic obstruction: Data from a retrospective regional SIED-AIGO study" by R. Di Mitri, F. Mocciaro, M. Traina et al. [Digestive and Liver Disease 2014;46:279-82]
Di Mitri, Roberto
Mocciaro, Filippo
DIGESTIVE AND LIVER DISEASE, 2014, 46 (09) : 861 - 861
[29] Response to the comments by the authors Hamed Jalilian et al. On: What is the radiation before 5G? A correlation study between measurements in situ and in real time and epidemiological indicators in Vallecas, Madrid, by I. Lopez, N. Felix, M. Rivera, A. Alonso, and C. Maestu. Environmental Health 10.1016/j.envres.2021.110734
Lopez, Isabel
Felix, Nazario
Rivera, Marco
Alonso, Adrian
Maestu, Ceferino
ENVIRONMENTAL RESEARCH, 2022, 209
[30] COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan et al, 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al' by Andreica et al and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin et al
Gianfrancesco, Milena
Hyrich, Kimme L.
Yazdany, Jinoos
Machado, Pedro M.
Robinson, Philip C.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10)

← 1 2 3 →